Integrity Alliance’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Integrity Alliance's VRTX Position: Q2 2026 in Review
Integrity Alliance increased its Vertex Pharmaceuticals (VRTX) stake by 24% in Q2 2026, buying an estimated $63.8K and bringing the position to 732 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #603.
Integrity Alliance first reported a position in VRTX in Q1 2025 and has held it in 4 quarters since. The position peaked at $445K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Integrity Alliance held 732 shares of Vertex Pharmaceuticals worth $364K as of Q2 2026.
- Integrity Alliance bought 144 Vertex Pharmaceuticals shares in Q2 2026, an estimated $63.8K.
- Vertex Pharmaceuticals made up 0.01% of Integrity Alliance's portfolio in Q2 2026, its #603 holding.
- Integrity Alliance first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
- Integrity Alliance's Vertex Pharmaceuticals position peaked at $445K in Q1 2025.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.